167 related articles for article (PubMed ID: 15353507)
1. Effectiveness of beta-blockade in experimental chronic aortic regurgitation.
Plante E; Lachance D; Gaudreau M; Drolet MC; Roussel E; Arsenault M; Couet J
Circulation; 2004 Sep; 110(11):1477-83. PubMed ID: 15353507
[TBL] [Abstract][Full Text] [Related]
2. Benefits of long-term beta-blockade in experimental chronic aortic regurgitation.
Plante E; Lachance D; Champetier S; Drolet MC; Roussel E; Arsenault M; Couet J
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1888-95. PubMed ID: 18296565
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of carvedilol in the treatment of chronic aortic valve regurgitation.
Zendaoui A; Lachance D; Roussel E; Couet J; Arsenault M
Circ Heart Fail; 2011 Mar; 4(2):207-13. PubMed ID: 21216836
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction.
Ahmet I; Krawczyk M; Zhu W; Woo AY; Morrell C; Poosala S; Xiao RP; Lakatta EG; Talan MI
J Pharmacol Exp Ther; 2008 May; 325(2):491-9. PubMed ID: 18287209
[TBL] [Abstract][Full Text] [Related]
5. Gene profiling of left ventricle eccentric hypertrophy in aortic regurgitation in rats: rationale for targeting the beta-adrenergic and renin-angiotensin systems.
Champetier S; Bojmehrani A; Beaudoin J; Lachance D; Plante E; Roussel E; Couet J; Arsenault M
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H669-77. PubMed ID: 19112094
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibitor captopril prevents volume overload cardiomyopathy in experimental chronic aortic valve regurgitation.
Plante E; Gaudreau M; Lachance D; Drolet MC; Roussel E; Gauthier C; Lapointe E; Arsenault M; Couet J
Can J Physiol Pharmacol; 2004 Mar; 82(3):191-9. PubMed ID: 15052285
[TBL] [Abstract][Full Text] [Related]
7. Gender-related differences in left ventricular remodeling in chronic severe aortic valve regurgitation in rats.
Drolet MC; Lachance D; Plante E; Roussel E; Couet J; Arsenault M
J Heart Valve Dis; 2006 May; 15(3):345-51. PubMed ID: 16784070
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy.
Ahmet I; Krawczyk M; Heller P; Moon C; Lakatta EG; Talan MI
Circulation; 2004 Aug; 110(9):1083-90. PubMed ID: 15313944
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological stimulation of beta2-adrenergic receptors (beta2AR) enhances therapeutic effectiveness of beta1AR blockade in rodent dilated ischemic cardiomyopathy.
Ahmet I; Lakatta EG; Talan MI
Heart Fail Rev; 2005 Dec; 10(4):289-96. PubMed ID: 16583177
[TBL] [Abstract][Full Text] [Related]
10. Sympathetic activation causes focal adhesion signaling alteration in early compensated volume overload attributable to isolated mitral regurgitation in the dog.
Sabri A; Rafiq K; Seqqat R; Kolpakov MA; Dillon R; Dell'italia LJ
Circ Res; 2008 May; 102(9):1127-36. PubMed ID: 18356543
[TBL] [Abstract][Full Text] [Related]
11. Early left ventricular remodeling in acute severe aortic regurgitation: insights from an animal model.
Lachance D; Plante E; Roussel E; Drolet MC; Couet J; Arsenault M
J Heart Valve Dis; 2008 May; 17(3):300-8. PubMed ID: 18592927
[TBL] [Abstract][Full Text] [Related]
12. [The effects of combined beta(1) adrenergic receptor antagonist and beta(2) adrenergic receptor agonist therapy on cardiac function and myocardial apoptosis in heart failure rats].
Li WM; Gan RT; Wang X; Wu S; Shen JX; Xiu CH
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):615-9. PubMed ID: 17961425
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II-converting enzyme inhibition improves survival, ventricular remodeling, and myocardial energetics in experimental aortic regurgitation.
Arsenault M; Zendaoui A; Roussel E; Drolet MC; Dhahri W; Grenier A; Gascon S; Sarrhini O; Rousseau JA; Lecomte R; Couet J
Circ Heart Fail; 2013 Sep; 6(5):1021-8. PubMed ID: 23861486
[TBL] [Abstract][Full Text] [Related]
14. Controlled release metoprolol for aortic regurgitation: a randomised clinical trial.
Broch K; Urheim S; Lønnebakken MT; Stueflotten W; Massey R; Fosså K; Hopp E; Aakhus S; Gullestad L
Heart; 2016 Feb; 102(3):191-7. PubMed ID: 26661319
[TBL] [Abstract][Full Text] [Related]
15. Comparison of effects of losartan and metoprolol on left ventricular and aortic function at rest and during exercise in chronic aortic regurgitation.
Roberts PA; Lin ACW; Cowan BR; Young AA; Stewart R
Int J Cardiovasc Imaging; 2018 Apr; 34(4):615-624. PubMed ID: 29119275
[TBL] [Abstract][Full Text] [Related]
16. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
Kobayashi M; Machida N; Mitsuishi M; Yamane Y
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
[TBL] [Abstract][Full Text] [Related]
17. Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart.
Maczewski M; Mackiewicz U
Cardiovasc Res; 2008 Jul; 79(1):42-51. PubMed ID: 18310678
[TBL] [Abstract][Full Text] [Related]
18. Dissociation between cardiomyocyte function and remodeling with beta-adrenergic receptor blockade in isolated canine mitral regurgitation.
Pat B; Killingsworth C; Denney T; Zheng J; Powell P; Tillson M; Dillon AR; Dell'Italia LJ
Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2321-7. PubMed ID: 18849331
[TBL] [Abstract][Full Text] [Related]
19. Endurance training or beta-blockade can partially block the energy metabolism remodeling taking place in experimental chronic left ventricle volume overload.
Lachance D; Dhahri W; Drolet MC; Roussel É; Gascon S; Sarrhini O; Rousseau JA; Lecomte R; Arsenault M; Couet J
BMC Cardiovasc Disord; 2014 Dec; 14():190. PubMed ID: 25518920
[TBL] [Abstract][Full Text] [Related]
20. Selective beta1-blockade attenuates post-infarct remodelling without improvement in myocardial energy metabolism and function in rats with heart failure.
Omerovic E; Bollano E; Soussi B; Waagstein F
Eur J Heart Fail; 2003 Dec; 5(6):725-32. PubMed ID: 14675850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
